In line with tumor tissue sequencing results (Table 1), the TP53 c.833C>T of circulating tumor DNA represented the dominant tumor clone from initial diagnosis to end of treatment, thus serving as a surrogate marker for overall tumor burden over time (Fig. 1F). The gene discussed is TP53; the disease is neoplasm.